Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy

Journal of Clinical Psychiatry

Volumn 60, Issue 3, 1999, Pages 187-190

  Nafziger, Anne N ^a,b   Bertino Jr , Joseph S ^a,b   Goss Bley, Angelica I ^a   Kashuba, Angela D M ^a,b  

^a BASSETT RESEARCH INSTITUTE   (United States)

^b BASSETT HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; FLUVOXAMINE MALEATE;

ADULT; ARTICLE; DEPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPOTENCE; INCIDENCE; LIBIDO; MALE; PRIORITY JOURNAL; SEXUAL DYSFUNCTION;

EID: 0032946287     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0307     Document Type: Article

References (33)

1. LePen C, Levy E, Ravily V, et al. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs tricyclis. J Affect Disord 1994;31:1-18
2. Mitchell J, Greenberg J, Finch K, et al. Effectiveness and economic impact of antidepressant medications: a review. Am J Man Care 1997;3: 323-330
3. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897-1902
4. Patterson WM. Fluoxetine-induced sexual dysfunction [letter]. J Clin Psychiatry 1993;54:71
5. Balon R, Yeragani VK, Pohl R, et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-212
6. Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-122
7. Corso DM, Pucino F, DeLeo JM, et al. Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother 1992; 26:890-896
8. Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry 1995;56(suppl 2):38-48
9. Goodwin GM. How do antidepressants affect serotonin receptors? the role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. J Clin Psychiatry 1996;57(suppl 4):9-13
10. Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997;61:476-487
11. Segraves RT. Antidepressant-induced orgasm disorder. J Sex Marital Ther 1995;21:192-201
12. Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine [letter]. J Clin Psychopharmacol 1984;4:169
13. Rivard DJ. Anatomy, physiology, and neurophysiology of male sexual function. In: Bennet AH, ed. Management of Male Impotence. Baltimore, Md: Williams & Wilkins; 1982:1-25
14. Nueten JM, Van Leysen JE, deClerck F, et al. Serotonergic receptor subtypes and vascular reactivity. J Pharmacol 1984;6:5564-5574
15. Zajecka J, Fawcett J, Schaff M, et al. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991;52:66-68
16. Mathew RJ, Weinman M, Claghorn JL. Tricyclic side effects without tricyclics in depression. Psychopharmacol Bull 1980;16:58-60
17. Harrison WM, Rabkin JG, Ehrhardt AA, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 1986;6:144-149
18. Reynolds RD. Sertraline-induced anorgasmia treated with intermittent nefazodone [letter]. J Clin Psychiatry 1997;58:89
19. Lesko LM, Stotland NL, Segraves RT. Three cases of female anorgasmia associated with MAOIs. Am J Psychiatry 1982;139:1353-1354
20. Prozac (fluoxetine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997:935-940
21. Luvox (fluvoxamine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997;2723-2726
22. Zoloft (sertraline). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997;2051-2053
23. Paxil (paroxetine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997;2681-2686
24. Benazzi F, Mazzoli M. Fluoxetine-induced sexual dysfunction: a dose-dependent effect? Pharmacopsychiatry 1994;27:246
25. Richelson E. Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 1994;69:1069-1081
26. Dorevitch A, Davis H. Fluvoxamine-associated sexual dysfunction. Ann Pharmacother 1994;28:872-874
27. Goodman WK, Ward H, Kablinger A, et al. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry 1997;58(suppl 5):32-49
28. Freeman EW, Rickels K, Sondheimer SJ. Fluvoxamine for premenstrual dysphoric disorder a pilot study. J Clin Psychiatry 1996;57(suppl 8): 56-59
29. Nemeth A, Arato M, Treuer T, et al. Treatment of fluvoxamine-induced anorgasmia with a partial drug holiday [letter]. Am J Psychiatry 1996; 153:1365
30. Spiegel DA, Saeed SA, Bruce TJ. An open trial of fluvoxamine therapy for panic disorder complicated by depression. J Clin Psychiatry 1996; 57(suppl 8):37-41
31. Couper-Smartt JD, Rodham R. A technique for surveying side-effects of tricyclic drugs with reference to reported sexual effects. J Int Med Res 1973;1:473-476
32. Ellingrod VL, Perry PJ. Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 1994;51:3033-3046
33. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int J Psychiatry Med 1995;25:239-248